First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2025-12-15
Target enrollment:
Participant gender:
Summary
This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and
antitumor activity of UCT-03-008 in patients with advanced solid tumors.